Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 1998

View Archived Issues

Company Profile: Nortran

Dura: Q4 and FY 1997 highlights

Antifibrotic compounds discovered at Hoechst

TIMI 12 trial results published

Heterocyclic bradykinin antagonists from Hoechst

Hoechst reveals several series of Na+/H+ exchange inhibitors

Name change and relocation announced

Beneficial effects of vitamin C demonstrated in heart failure patients

Strategies for purging latently infected cells in HIV-positive patients studied at NIAID

NexMed completes phase I trial of ED product

Phase III trial compares immediate and delayed treatment with fomivirsen for CMV retinitis

New targets for stroke: neurotrophic growth factors

PRO-2000 gel well tolerated in phase I trial in healthy females

Preclinical studies support potential of CP-358774 as cancer treatment

StressGen licenses heat shock transcription factors

Neuroprotective effects of IL-1ra

Glaxo Wellcome characterizes in vitro/in vivo antibacterial activity of new trinem

Neuroprotective activity described for CoCensys neurosteroid

Pharmacia & Upjohn and Chiron establish HCV collaboration

Zeneca receives patent protection for new Diprivan formulation

New formulation of enalapril now available in U.K.

Promising preclinical results reported for Resolve

Potent SK(Ca) channel blocker prepared by European university researchers

Asacard approved in U.K.

Continued HIV suppression requires triple drug maintenance therapy

AVI BioPharma on the way to finalizing ImmunoTherapy acquisition

Abgenix and Schering-Plough collaborate on XenoMouse antibodies

FDA issues approvable letter for BioLon

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...